Progress in adjuvant therapy of hepatocellular carcinoma complicated with microvascular invasion
10.3760/cma.j.cn371439-20230314-00061
- VernacularTitle:肝细胞癌合并微血管侵犯术后辅助治疗现状
- Author:
Fang XU
1
;
Wentian ZHU
Author Information
1. 广东医科大学第一临床学院，湛江 524000
- Keywords:
Carcinoma, hepatocellular;
Neoadjuvant therapy;
Microvascular invasion
- From:
Journal of International Oncology
2023;50(5):304-309
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma is a highly aggressive malignant tumor. Although the progress of surgical technology has made some achievements in surgical treatment alone, it still fails to significantly improve the long-term survival of patients. Studies have shown that the recurrence rate of hepatocellular carcinoma is extremely high, while microvascular invasion is an important reason for early recurrence and poor prognosis. Therefore, appropriate postoperative adjuvant therapy measures are crucial to improve the survival prognosis of hepatocellular carcinoma patients with microvascular invasion.
